United States · FDA National Drug Code directory
Clobazam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-401_df4d6b4b-9864-4c24-92e1-4a72c2863b5f
- Product NDC
- 59651-401
- Form
- SUSPENSION
- Composition / generic term
- Clobazam
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220324
- Source listing expiry
- 20261231
Source-listed ingredients
- CLOBAZAM — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59651-401-12) / 120 mL in 1 BOTTLE · 59651-401-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →